Central Plains Bancshares, Inc. Common Stock
NASDAQ:CPBIShell Companies
-$0.18 today
- Market cap
- $85.57M
- Beta
- 0.21
- P/E (TTM)
- 18.0
- EPS (TTM)
- $1.03
Volume 0.00M
Average 0.00M
CPBI Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Central Plains Bancshares, Inc. Common StockNASDAQ: CPBI
Research & Development · Q3 FY2025 · quarter ended Dec 2025
Research & development remains negative
Q3 FY2025 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2024, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2024 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2024
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 0 | — |
| FY2023 | 2024-03-31 | 0 | — |
| FY2022 | 2023-03-31 | 0 | — |
| FY2021 | 2022-03-31 | 0 | — |
Research & Development vs competitors
How CPBI compares with its peers on the latest reported figures
- CPBI's LTM Dec 2025 research & development of $0 is the highest of the 8 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for CPBI, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Dec 2025 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
ORIQUOrigin Investment Corp I Units | LTM Mar 2026 | $0 | — | — | — |
| LTM Mar 2026 | $0 | — | — | — | |
AFJKAimei Health Technology Co., Ltd | LTM Mar 2026 | $0 | — | — | — |
| LTM Mar 2026 | $0 | — | — | — | |
| Peer median (excluding CPBI) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for CPBI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Mar 2022 | FY2022 Mar 2023 | FY2023 Mar 2024 | FY2024 Mar 2025 |
|---|---|---|---|---|
| Revenue | 15.68M | 18.42M | 23.82M | 27.31M |
| Cost of Revenue | 965K | 5.62M | 6.58M | 8.41M |
| Gross Profit | 14.71M | 12.8M | 17.24M | 18.9M |
| Gross Margin | 93.8% | 69.5% | 72.4% | 69.2% |
| Research & Development | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 6.65M | 6.18M | 7.47M | 8.49M |
| Operating Expenses | 10.97M | 10.84M | 12.6M | 14.38M |
| Depreciation & Amortization | 497K | 503K | 518K | 455K |
| EBITDA | 4.24M | 2.47M | 5.15M | 4.98M |
| EBITDA Margin | 27.0% | 13.4% | 21.6% | 18.2% |
| Operating Income | 3.74M | 1.96M | 4.64M | 4.52M |
| Operating Margin | 23.9% | 10.7% | 19.5% | 16.6% |
| Interest Income | 13.17M | 16.14M | 20.96M | 24.7M |
| Interest Expense | 1.08M | 2.74M | 6.49M | 8.21M |
| Other Income / Expenses | 0 | 0 | 0 | 0 |
| Income Before Tax | 3.74M | 1.96M | 4.64M | 4.52M |
| Pre-Tax Margin | 23.9% | 10.7% | 19.5% | 16.6% |
| Income Tax Expense | 595K | 317K | 877K | 869K |
| Net Income | 3.15M | 1.65M | 3.76M | 3.65M |
| Net Margin | 20.1% | 8.9% | 15.8% | 13.4% |
| EPS (Basic) | 0.86 | 0.45 | 1.10 | 0.96 |
| EPS (Diluted) | 0.86 | 0.40 | 1.10 | 0.96 |
| Weighted Avg Shares | 3.68M | 3.68M | 3.44M | 3.82M |
| Weighted Avg Shares (Diluted) | 3.68M | 4.13M | 3.44M | 3.82M |
Central Plains Bancshares, Inc. Common Stock
NASDAQ:CPBI
Intrinsic Alpha fair value
Locked
Current Price
$20.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.